Regulatory Insights

  1. A Practical Guide For Managing Multiple Global Regulatory Pathways 5/27/2026

    Global submissions are getting faster—and more complex. Explore a 7-step framework for aligning FDA and EMA pathways to reduce risk, duplication, and regulatory delays.

  2. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

    Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

  3. Successful EU MAA Submission Enabled By U.S.–EU Regulatory Collaboration 5/27/2026

    Facing EU MAA complexity? Learn how one oncology sponsor met a fixed EMA deadline through global regulatory coordination, rapid dossier adaptation, and real-time submission execution.

  4. Does Your CRO Excel In Oncology Regulatory Publishing? 5/27/2026

    Oncology approvals move fast. Learn how experienced CRO publishing teams help sponsors navigate RTOR, Project Orbis, and complex global submissions with confidence.

  5. Relieving Pressure During Preparation Of A High-Volume sNDA 5/27/2026

    Managing a complex sNDA under pressure? See how one sponsor achieved an early FDA submission through coordinated publishing, regulatory strategy, and flawless execution.

  6. Supporting Global Approval Of A First-In-Class Gene Therapy For A Rare Genetic Disorder 5/27/2026

    Global approvals for a first-in-class gene therapy don’t happen by chance. See how adaptive oversight and inspection readiness kept a complex rare disease program moving forward.

  7. How ReTrans Supports Smarter Literature Surveillance In Pharmacovigilance 5/26/2026

    Smarter literature surveillance uses automation, expert review, and targeted translation to handle growing volumes, improve signal detection, and reduce manual PV workload.

  8. From Submission Document To Lifecycle Safety Tool: Why RMPs Need Ongoing Attention 5/26/2026

    Actively maintained risk management plans improve safety oversight, data alignment, and regulatory confidence well beyond initial approval milestones.

  9. How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch 5/26/2026

    Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.

  10. Inspection Facilitation Without Local MAH Presence 5/26/2026

    Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.